Human CD38/ADPRC 1 HEK293T Stable Cell Line

Introduction

Human CD38/ADPRC 1 is a transmembrane glycoprotein that belongs to the ADP-ribosyl cyclase family. It is expressed on the surface of various immune cells, including T cells, B cells, natural killer cells, and dendritic cells. CD38 plays a crucial role in immune response regulation and has been identified as a potential therapeutic target for various diseases. In this article, we will provide a scientific description of the structure, activity, and application of the Human CD38/ADPRC 1 HEK293T Stable Cell Line.

Structure of Human CD38/ADPRC 1

The Human CD38/ADPRC 1 gene is located on chromosome 4 and consists of 11 exons. The protein has a molecular weight of approximately 45 kDa and is composed of 300 amino acids. CD38 contains a single transmembrane domain, a cytoplasmic tail, and an extracellular domain. The extracellular domain consists of a catalytic domain and a C-terminal domain. The catalytic domain is responsible for the enzymatic activity of CD38, while the C-terminal domain is involved in protein-protein interactions.

Activity of Human CD38/ADPRC 1

CD38 is a multifunctional protein with both enzymatic and non-enzymatic activities. Its main enzymatic activity is the conversion of NAD+ to cyclic ADP-ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP). These products act as second messengers and play a crucial role in calcium signaling, which is essential for immune cell activation and proliferation.

In addition to its enzymatic activity, CD38 also has non-enzymatic functions. It acts as a receptor for CD31, a cell adhesion molecule, and is involved in cell-cell interactions. CD38 also functions as a receptor for CD31, a cell adhesion molecule, and is involved in cell-cell interactions. Moreover, CD38 has been shown to modulate the activity of other immune receptors, such as the T cell receptor and the B cell receptor.

Application of Human CD38/ADPRC 1 HEK293T Stable Cell Line

The Human CD38/ADPRC 1 HEK293T Stable Cell Line is a valuable tool for studying the function of CD38 and its potential as a therapeutic target. This cell line is stably transfected with the human CD38 gene and expresses high levels of CD38 on the cell surface. It can be used for various applications, including flow cytometry, functional assays, and drug screening.

Flow cytometry is a powerful technique that allows the analysis of cell surface markers and intracellular proteins. The Human CD38/ADPRC 1 HEK293T Stable Cell Line can be used in flow cytometry experiments to study the expression and function of CD38 on immune cells. It can also be used to assess the binding of potential CD38-targeting drugs.

Functional assays, such as proliferation and cytokine production assays, can be performed using the Human CD38/ADPRC 1 HEK293T Stable Cell Line. These assays can provide valuable insights into the role of CD38 in immune cell activation and proliferation.

Moreover, the Human CD38/ADPRC 1 HEK293T Stable Cell Line can be used in drug screening assays to identify potential CD38 inhibitors or activators. As CD38 has been implicated in various diseases, such as cancer, autoimmune disorders, and infectious diseases, targeting this protein could have therapeutic benefits.

Conclusion

In summary, the Human CD38/ADPRC 1 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of CD38. This cell line allows for the analysis of CD38 expression and function, as well as the screening of potential CD38-targeting drugs.